| Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test AC Lionel, G Costain, N Monfared, S Walker, MS Reuter, SM Hosseini, ... Genetics in Medicine 20 (4), 435-443, 2018 | 559 | 2018 |
| Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing G Costain, R Jobling, S Walker, MS Reuter, M Snell, S Bowdin, RD Cohn, ... European Journal of Human Genetics 26 (5), 740-744, 2018 | 136 | 2018 |
| Natural history of vanishing white matter EMC Hamilton, HDW van der Lei, G Vermeulen, JAM Gerver, ... Annals of neurology 84 (2), 274-288, 2018 | 110 | 2018 |
| Clinical application of targeted next-generation sequencing panels and whole exome sequencing in childhood epilepsy G Costain, D Cordeiro, D Matviychuk, S Mercimek-Andrews Neuroscience 418, 291-310, 2019 | 102 | 2019 |
| AADC deficiency from infancy to adulthood: symptoms and developmental outcome in an international cohort of 63 patients TS Pearson, L Gilbert, T Opladen, A Garcia‐Cazorla, M Mastrangelo, ... Journal of inherited metabolic disease 43 (5), 1121-1130, 2020 | 79 | 2020 |
| Heterozygous variants in KMT2E cause a spectrum of neurodevelopmental disorders and epilepsy AH O’Donnell-Luria, LS Pais, V Faundes, JC Wood, A Sveden, V Luria, ... The American Journal of Human Genetics 104 (6), 1210-1222, 2019 | 74 | 2019 |
| Disruptive mutations in TANC2 define a neurodevelopmental syndrome associated with psychiatric disorders H Guo, E Bettella, PC Marcogliese, R Zhao, JC Andrews, TJ Nowakowski, ... Nature communications 10 (1), 4679, 2019 | 60 | 2019 |
| Histone H3.3 beyond cancer: Germline mutations in Histone 3 Family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients L Bryant, D Li, SG Cox, D Marchione, EF Joiner, K Wilson, K Janssen, ... Science advances 6 (49), eabc9207, 2020 | 59 | 2020 |
| Prospective cohort study for identification of underlying genetic causes in neonatal encephalopathy using whole-exome sequencing TUJ Bruun, CL DesRoches, D Wilson, V Chau, T Nakagawa, M Yamasaki, ... Genetics in Medicine 20 (5), 486-494, 2018 | 59 | 2018 |
| Neonatal encephalopathy: Etiologies other than hypoxic-ischemic encephalopathy AGS Karamian, S Mercimek-Andrews, K Mohammad, EJ Molloy, T Chang, ... Seminars in Fetal and Neonatal Medicine 26 (5), 101272, 2021 | 50 | 2021 |
| Partial loss of USP9X function leads to a male neurodevelopmental and behavioral disorder converging on transforming growth factor β signaling BV Johnson, R Kumar, S Oishi, S Alexander, M Kasherman, MS Vega, ... Biological psychiatry 87 (2), 100-112, 2020 | 50 | 2020 |
| De novo and inherited loss-of-function variants in TLK2: clinical and genotype-phenotype evaluation of a distinct neurodevelopmental disorder MRF Reijnders, KA Miller, M Alvi, JAC Goos, MM Lees, A De Burca, ... The American Journal of Human Genetics 102 (6), 1195-1203, 2018 | 49 | 2018 |
| Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy UFH Engelke, RE Van Outersterp, J Merx, FAMG Van Geenen, ... The Journal of clinical investigation 131 (15), 2021 | 48 | 2021 |
| De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy AG Sega, EK Mis, K Lindstrom, S Mercimek-Andrews, W Ji, MT Cho, ... Journal of Medical Genetics 56 (2), 113-122, 2019 | 46 | 2019 |
| Person ability scores as an alternative to norm-referenced scores as outcome measures in studies of neurodevelopmental disorders CA Farmer, AJ Kaat, A Thurm, I Anselm, N Akshoomoff, A Bennett, L Berry, ... American Journal on Intellectual and Developmental Disabilities 125 (6), 475-480, 2020 | 45 | 2020 |
| Sorbitol is a severity biomarker for PMM2‐CDG with therapeutic implications AN Ligezka, S Radenkovic, M Saraswat, K Garapati, W Ranatunga, ... Annals of neurology 90 (6), 887-900, 2021 | 40 | 2021 |
| Treatment outcome of creatine transporter deficiency: international retrospective cohort study TUJ Bruun, S Sidky, AO Bandeira, FG Debray, C Ficicioglu, J Goldstein, ... Metabolic brain disease 33, 875-884, 2018 | 40 | 2018 |
| Characterization of the first knock-out aldh7a1 zebrafish model for pyridoxine-dependent epilepsy using CRISPR-Cas9 technology N Zabinyakov, G Bullivant, F Cao, M Fernandez Ojeda, ZP Jia, XY Wen, ... PloS one 12 (10), e0186645, 2017 | 39 | 2017 |
| Genetic landscape of pediatric movement disorders and management implications D Cordeiro, G Bullivant, K Siriwardena, A Evans, J Kobayashi, RD Cohn, ... Neurology: Genetics 4 (5), e265, 2018 | 38 | 2018 |
| Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort study Y Khaikin, S Sidky, J Abdenur, A Anastasi, D Ballhausen, S Buoni, ... European Journal of Paediatric Neurology 22 (3), 369-379, 2018 | 37 | 2018 |
